Tilray Brands Inc (TLRY)
1.395
-0.05
(-3.46%)
USD |
NASDAQ |
Nov 14, 13:12
Tilray Brands Enterprise Value: 1.353B for Nov. 13, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 13, 2024 | 1.353B |
| November 12, 2024 | 1.375B |
| November 11, 2024 | 1.312B |
| November 08, 2024 | 1.393B |
| November 07, 2024 | 1.447B |
| November 06, 2024 | 1.438B |
| November 05, 2024 | 1.646B |
| November 04, 2024 | 1.610B |
| November 01, 2024 | 1.529B |
| October 31, 2024 | 1.529B |
| October 30, 2024 | 1.574B |
| October 29, 2024 | 1.592B |
| October 28, 2024 | 1.610B |
| October 25, 2024 | 1.574B |
| October 24, 2024 | 1.529B |
| October 23, 2024 | 1.565B |
| October 22, 2024 | 1.592B |
| October 21, 2024 | 1.475B |
| October 18, 2024 | 1.484B |
| October 17, 2024 | 1.466B |
| October 16, 2024 | 1.475B |
| October 15, 2024 | 1.466B |
| October 14, 2024 | 1.484B |
| October 11, 2024 | 1.520B |
| October 10, 2024 | 1.484B |
| Date | Value |
|---|---|
| October 09, 2024 | 1.520B |
| October 08, 2024 | 1.538B |
| October 07, 2024 | 1.492B |
| October 04, 2024 | 1.527B |
| October 03, 2024 | 1.536B |
| October 02, 2024 | 1.518B |
| October 01, 2024 | 1.518B |
| September 30, 2024 | 1.588B |
| September 27, 2024 | 1.571B |
| September 26, 2024 | 1.571B |
| September 25, 2024 | 1.518B |
| September 24, 2024 | 1.553B |
| September 23, 2024 | 1.527B |
| September 20, 2024 | 1.553B |
| September 19, 2024 | 1.606B |
| September 18, 2024 | 1.623B |
| September 17, 2024 | 1.632B |
| September 16, 2024 | 1.623B |
| September 13, 2024 | 1.571B |
| September 12, 2024 | 1.536B |
| September 11, 2024 | 1.553B |
| September 10, 2024 | 1.536B |
| September 09, 2024 | 1.536B |
| September 06, 2024 | 1.466B |
| September 05, 2024 | 1.518B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
546.09M
Minimum
Mar 18 2020
17.25B
Maximum
Feb 10 2021
2.966B
Average
2.029B
Median
Enterprise Value Benchmarks
| Aurinia Pharmaceuticals Inc | 836.78M |
| Edesa Biotech Inc | 5.103M |
| Lexaria Bioscience Corp | 26.69M |
| Xenon Pharmaceuticals Inc | 2.455B |
| ESSA Pharma Inc | -51.27M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -39.16M |
| Revenue (Quarterly) | 200.04M |
| Total Expenses (Quarterly) | 229.64M |
| EPS Diluted (Quarterly) | -0.04 |
| Gross Profit Margin (Quarterly) | 29.85% |
| Profit Margin (Quarterly) | -19.58% |
| Earnings Yield | -19.35% |
| Normalized Earnings Yield | -16.82 |